These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10069551)

  • 1. Ritanserin in relapse prevention in abstinent alcoholics: results from a placebo-controlled double-blind international multicenter trial. Ritanserin in Alcoholism Work Group.
    Wiesbeck GA; Weijers HG; Chick J; Naranjo CA; Boening J
    Alcohol Clin Exp Res; 1999 Feb; 23(2):230-5. PubMed ID: 10069551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ritanserin in the treatment of alcohol dependence--a multi-center clinical trial. Ritanserin Study Group.
    Johnson BA; Jasinski DR; Galloway GP; Kranzler H; Weinreib R; Anton RF; Mason BJ; Bohn MJ; Pettinati HM; Rawson R; Clyde C
    Psychopharmacology (Berl); 1996 Nov; 128(2):206-15. PubMed ID: 8956382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of ritanserin on mood, sleep, vigilance, clinical impression, and social functioning in alcohol-dependent individuals. Ritanserin in Alcoholism Work Group.
    Wiesbeck GA; Weijers HG; Chick J; Boening J
    Alcohol Alcohol; 2000; 35(4):384-9. PubMed ID: 10906006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ritanserin, a central 5-HT2 antagonist, in heavy social drinkers: desire to drink, alcohol intake and related effects.
    Naranjo CA; Poulos CX; Lanctôt KL; Bremner KE; Kwok M; Umana M
    Addiction; 1995 Jul; 90(7):893-905. PubMed ID: 7663312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ritanserin as an adjunct to lithium and haloperidol for the treatment of medication-naive patients with acute mania: a double blind and placebo controlled trial.
    Akhondzadeh S; Mohajari H; Reza Mohammadi M; Amini H
    BMC Psychiatry; 2003 Jun; 3():7. PubMed ID: 12816549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-HT2 receptor antagonism in dysthymic disorder: a double-blind placebo-controlled study with ritanserin.
    Bersani G; Pozzi F; Marini S; Grispini A; Pasini A; Ciani N
    Acta Psychiatr Scand; 1991 Apr; 83(4):244-8. PubMed ID: 1903019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ritanserin in the treatment of cocaine dependence.
    Johnson BA; Chen YR; Swann AC; Schmitz J; Lesser J; Ruiz P; Johnson P; Clyde C
    Biol Psychiatry; 1997 Nov; 42(10):932-40. PubMed ID: 9359980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Addiction and the potential for therapeutic drug development.
    Janssen PA
    EXS; 1994; 71():361-70. PubMed ID: 8032167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure of ritanserin to block cocaine cue reactivity in humans.
    Ehrman RN; Robbins SJ; Cornish JW; Childress AR; O'Brien CP
    Drug Alcohol Depend; 1996 Nov; 42(3):167-74. PubMed ID: 8912799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind, placebo-controlled pilot trial of quetiapine for the treatment of Type A and Type B alcoholism.
    Kampman KM; Pettinati HM; Lynch KG; Whittingham T; Macfadden W; Dackis C; Tirado C; Oslin DW; Sparkman T; O'Brien CP
    J Clin Psychopharmacol; 2007 Aug; 27(4):344-51. PubMed ID: 17632217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acetyl-L-carnitine for alcohol craving and relapse prevention in anhedonic alcoholics: a randomized, double-blind, placebo-controlled pilot trial.
    Martinotti G; Reina D; Di Nicola M; Andreoli S; Tedeschi D; Ortolani I; Pozzi G; Iannoni E; D'Iddio S; Janiri L
    Alcohol Alcohol; 2010; 45(5):449-55. PubMed ID: 20595193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ondansetron for reduction of drinking among biologically predisposed alcoholic patients: A randomized controlled trial.
    Johnson BA; Roache JD; Javors MA; DiClemente CC; Cloninger CR; Prihoda TJ; Bordnick PS; Ait-Daoud N; Hensler J
    JAMA; 2000 Aug 23-30; 284(8):963-71. PubMed ID: 10944641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomised double-blind 16-week study of ritanserin in fibromyalgia syndrome: clinical outcome and analysis of autoantibodies to serotonin, gangliosides and phospholipids.
    Olin R; Klein R; Berg PA
    Clin Rheumatol; 1998; 17(2):89-94. PubMed ID: 9641502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ritanserin and alcohol abuse and dependence.
    Meert TF
    Alcohol Alcohol Suppl; 1994; 2():523-30. PubMed ID: 8974378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ritanserin improves sleep quality in narcolepsy.
    Mayer G
    Pharmacopsychiatry; 2003 Jul; 36(4):150-5. PubMed ID: 12905101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of ritanserin, a highly selective 5-HT2 receptor antagonist, on Parkinson's disease.
    Henderson J; Yiannikas C; Graham JS
    Clin Exp Neurol; 1992; 29():277-82. PubMed ID: 1343870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible pharmacological probes for predicting and preventing relapse in treated alcoholics.
    Naranjo CA; Kadlec KE
    Alcohol Alcohol Suppl; 1991; 1():523-6. PubMed ID: 1845592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baclofen efficacy in reducing alcohol craving and intake: a preliminary double-blind randomized controlled study.
    Addolorato G; Caputo F; Capristo E; Domenicali M; Bernardi M; Janiri L; Agabio R; Colombo G; Gessa GL; Gasbarrini G
    Alcohol Alcohol; 2002; 37(5):504-8. PubMed ID: 12217947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of ritanserin, a serotonin antagonist, in anxiety disorders: a double-blind placebo-controlled study versus lorazepam.
    Ceulemans DL; Hoppenbrouwers ML; Gelders YG; Reyntjens AJ
    Pharmacopsychiatry; 1985 Sep; 18(5):303-5. PubMed ID: 3931107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pilot double-blind treatment trial of memantine for alcohol dependence.
    Evans SM; Levin FR; Brooks DJ; Garawi F
    Alcohol Clin Exp Res; 2007 May; 31(5):775-82. PubMed ID: 17378918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.